Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the Cervix
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Peter G. Rose, MD
MetroHealth Cancer Care Center at MetroHealth Medical Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
17 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Norwegian Radium Hospital
Oslo, Norway
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Community Hospital of Los Gatos
Los Gatos, California, United States
- Mbccop - Hawaii
Honolulu, Hawaii, United States
- Holden Comprehensive Cancer Center at University of Iowa
Iowa City, Iowa, United States
- Warren Grant Magnuson Clinical Center - Nci Clinical Studies Support
Bethesda, Maryland, United States
- Tufts - New England Medical Center
Boston, Massachusetts, United States
- Cooper University Hospital
Camden, New Jersey, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- State University of New York Health Sciences Center - Stony Brook
Stony Brook, New York, United States
- Lineberger Comprehensive Cancer Center, Unc
Chapel Hill, North Carolina, United States
- Charles M. Barrett Cancer Center at University Hospital
Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio, United States
- Abington Memorial Hospital
Abington, Pennsylvania, United States
- University of Texas Medical Branch
Galveston, Texas, United States
- University of Texas M.D. Anderson Ccop Research Base
Houston, Texas, United States
- Fletcher Allen Health Care - Medical Center Campus
Burlington, Vermont, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2001
- Primary completion
- 31 Oct 2006
- Completion
- —
- Last update posted
- 11 Apr 2013
- Registered enrollment
- —
- Registry id
- NCT00030472
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.